Sigilon Therapeutics Inc

NASDAQ:SGTX   1:21:37 PM EDT
0.72
-0.01 (-1.37%)
Earnings Announcements

Sigilon Therapeutics Reports Second Quarter 2022 Financial Results And Business Highlights

Published: 08/04/2022 21:51 GMT
Sigilon Therapeutics Inc (SGTX) - Sigilon Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights.
Qtrly Net Loss per Share Attributable to Common Stockholders-basic and Diluted $0.44.
Q2 Earnings per Share View $-0.43 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.5 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $2.5 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.